-+ 0.00%
-+ 0.00%
-+ 0.00%

GRI Bio executives present at 10th IPF Summit on immune modulation, Phase 2a IPF data

PUBT·09/28/2026 12:40:16
Listen to the news
GRI Bio executives present at 10th IPF Summit on immune modulation, Phase 2a IPF data
  • GRI Bio will present at the 10th IPF Summit in Boston, Sept. 29 to Oct. 1, 2026.
  • CSO Vipin Kumar is scheduled to speak on Sept. 30 at 2:00 p.m. ET on translational development for IPF therapies.
  • CEO Marc Hertz is scheduled to speak on Oct. 1 at 1:30 p.m. ET on Phase 2a development insights for its IPF program.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gri Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609280840PRIMZONEFULLFEED9834094) on September 28, 2026, and is solely responsible for the information contained therein.